We are live on
!
Find out more
DVM
Dreman Value Management Portfolio holdings
AUM
$221M
1-Year Est. Return
11.98%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
+11.98%
3 Year Est. Return
+36.62%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
-$12.7M
(-1%)
Cap. Flow
-$27.4M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
11.3%
Holding
527
New
61
Increased
201
Reduced
176
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Old National Bancorp
ONB
|
+$8.53M |
| 2 |
TGI
Triumph Group
TGI
|
+$7.06M |
| 3 |
DNR
Denbury Resources, Inc.
DNR
|
+$5.5M |
| 4 |
Owens Corning
OC
|
+$4.64M |
| 5 |
DNY
DONNELLEY R R & SONS CO
DNY
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
URS
URS CORP
URS
|
+$9.9M |
| 2 |
Hawaiian Electric Industries
HE
|
+$9.2M |
| 3 |
CADE
Cadence Bank
CADE
|
+$7.21M |
| 4 |
ESL
Esterline Technologies
ESL
|
+$6.77M |
| 5 |
AstraZeneca
AZN
|
+$6.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.33% |
| 2 | Technology | 13.42% |
| 3 | Industrials | 13.26% |
| 4 | Real Estate | 7.02% |
| 5 | Consumer Discretionary | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Kohl's
KSS
$2.03B
| $2.19M | 0.18% |
35,870
+383
| +1% | +$22.1K |
|
177
KeyCorp
KEY
$24.3B
| $2.18M | 0.18% |
156,940
+3,592
| +2% | +$47.8K |
|
178
Quest Diagnostics
DGX
$25.1B
| $2.17M | 0.18% |
32,431
-1,467
| -4% | -$92.6K |
|
179
Bank of America
BAC
$435B
| $2.14M | 0.18% |
119,392
-7,142
| -6% | -$122K |
|
180
Corning
GLW
$126B
| $2.12M | 0.17% |
92,350
+11,059
| +14% | +$225K |
|
181
Citigroup
C
$222B
| $2.12M | 0.17% |
39,133
-644
| -2% | -$34.2K |
|
182
Allstate
ALL
$66.9B
| $2.11M | 0.17% |
29,979
-3,021
| -9% | -$199K |
|
|
BNY
183
Bank of New York Mellon
BNY
$108B
| $2.1M | 0.17% |
51,757
-723
| -1% | -$28.3K |
|
184
Ford
F
$57.3B
| $2.1M | 0.17% |
135,440
+452
| +0.3% | +$6.66K |
|
185
Aflac
AFL
$63.9B
| $2.09M | 0.17% |
68,532
-854
| -1% | -$25.2K |
|
186
MetLife
MET
$61B
| $2.09M | 0.17% |
43,344
-1,364
| -3% | -$64.8K |
|
|
187
AstraZeneca
AZN
$263B
| $2.02M | 0.17% |
28,764
-88,239
| -75% | -$6.32M |
|
|
CA
188
DELISTED
CA, Inc.
CA
| $2.02M | 0.17% |
66,188
-2,319
| -3% | -$67.8K |
|
189
Thermo Fisher Scientific
TMO
$211B
| $2M | 0.16% |
15,984
-229
| -1% | -$27.8K |
|
|
IXYS
190
DELISTED
IXYS Corp
IXYS
| $1.99M | 0.16% |
+158,236
| New | +$1.78M |
|
|
LLL
191
DELISTED
L3 Technologies, Inc.
LLL
| $1.99M | 0.16% |
15,778
-4,769
| -23% | -$570K |
|
192
Prospect Capital
PSEC
$1.06B
| $1.98M | 0.16% |
240,001
+3,081
| +1% | +$28.4K |
|
|
STJ
193
DELISTED
St Jude Medical
STJ
| $1.97M | 0.16% |
30,297
-1,036
| -3% | -$66.7K |
|
194
Prudential Financial
PRU
$41.7B
| $1.96M | 0.16% |
21,703
+18,249
| +528% | +$1.57M |
|
195
IBM
IBM
$202B
| $1.9M | 0.16% |
12,369
+291
| +2% | +$46.3K |
|
|
TA
196
DELISTED
TravelCenters of America LLC
TA
| $1.89M | 0.16% |
+29,961
| New | +$1.47M |
|
197
FedEx
FDX
$74.5B
| $1.86M | 0.15% |
10,689
-176
| -2% | -$29.8K |
|
198
Apple
AAPL
$4.89T
| $1.84M | 0.15% |
66,776
-3,292
| -5% | -$89.6K |
|
199
Foster
FSTR
$443M
| $1.84M | 0.15% |
37,948
+2,124
| +6% | +$104K |
|
200
AT&T
T
$165B
| $1.8M | 0.15% |
71,045
-1,028
| -1% | -$26.7K |
|
Similar funds
EP
PAM
GVT
FPF
USG2
PAM
HWP
IHM
Dreman Value Management's Q4 2014 Portfolio in Review
As of Q4 2014, Dreman Value Management held 527 positions worth $1.22B, down 1% from $1.23B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dreman Value Management's Q4 2014 filing shows 61 new, 201 increased, 176 reduced and 53 closed positions. Its largest new stake was Old National Bancorp: 608,592 shares worth $9.06M. The largest sale was URS CORP, an estimated $9.9M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.
- Dreman Value Management's largest Q4 2014 buy was Old National Bancorp: 608,592 shares worth $9.06M.
- Dreman Value Management added most to Denbury Resources, Inc. in Q4 2014, an estimated $5.5M increase.
- Dreman Value Management's biggest Q4 2014 reduction was AstraZeneca, cutting an estimated $6.32M.
- Dreman Value Management fully exited URS CORP in Q4 2014, selling an estimated $9.9M.
- Dreman Value Management's ten largest holdings make up 11% of its $1.22B portfolio in Q4 2014.
- Dreman Value Management opened 61 new positions and closed 53 in Q4 2014.
- Dreman Value Management's portfolio value fell 1% quarter-over-quarter to $1.22B.
Based on Dreman Value Management's 13F filing for Q4 2014, filed 23 Feb 2015.